Movement disorders

Movement Disorders Parkinson’s Epilepsy

Parkinson’s ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

The Parkinson Balancing Act Normal Balance Parkinson’s Disease Drug Therapy in Parkinson’s Acetylcholine Dopamine

Metabolism of Levodopa Levodopa 3,O-Methyldopa Dopamine Degradation products COMT COMT inhibitors

Treatment of Parkinson’s Amantadine, benztropin, diphenhydramine, trihexyphenidyl Miscellaneous Carbidopa-levodopa/entacapone (Stalevo) Increase DA & inhibit metabolism Selegiline(Eldepryl), Tolcapone (Tasmar), Entacapone (Comtan) Inhibit DA Metabolism Levodopa-carbidopa (Sinemet) Bromocriptine, Pergolide(Permax) Pramipexole(Mirapex), Ropinirole(Requip) Increase DA Stimulate DA receptors Agents Drug Action

Drug Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical Management ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object]

Points to Ponder ,[object Object],[object Object],[object Object],[object Object],[object Object]

Epilepsy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Overview of Triggers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical Management of Epilepsy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Seizure Type by Incidence Generalized Tonic-Clonic Partial Other

MOA of Anticonvulsants ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pharmacologic Agents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Management of Epilepsy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Movement disorders

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Movement disorders

Similar to Movement disorders (20)

More from Diana Rangaves, PharmD, CEO

More from Diana Rangaves, PharmD, CEO (20)

Recently uploaded

Recently uploaded (20)

Movement disorders